CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Adirondack Health

Henri P. Gaboriau MD, FACS, Head Of Department ENT/Facial Plastic and Reconstructive Surgery

Director of the Cosmetic and Reconstructive Center

Henri P. Gaboriau MD

Henri P. Gaboriau MD

As the number of patients with skin cancers increases dramatically (more than 9,500 per day) the need to streamline the process, from referral to evaluation to treatment becomes paramount.


Considering that Adirondack Health is a rural community hospital and patients must drive great distances to be able to receive care, such a process is important.


Referral: SCCA and Melanoma need to be addressed as soon as possible after being diagnosed. To minimize the interval between diagnosis and treatment, a direct line of communication between referring physicians and my office is necessary. At Adirondak Health, in addition of fax and Internet I have an encrypted phone. It allows me to receive pictures of lesions and copy of pathology reports as well as communicating instantly with the referring physician and let us elaborate a plan of action.


Surgeries: To accommodate both the increasing number of patients requiring surgery, as well as to accommodate for urgent surgical cases (SCCA and Melanoma), I have access to Operating rooms as well as Minor procedure rooms for a total of 2 days per week. Such flexibility allows me to minimize the delay between referral and surgical excision of the tumors, between 72 hours to 1 week maximum.


To minimize the interval between diagnosis and treatment, a direct line of communication between referring physicians and my office is necessary


Surgical Pathology: One of the challenges of advanced cancerous lesions in the Head and Neck region is obtaining clear margins BEFORE the patient goes back home, sometimes hours away. At Adirondack Health I work closely with our Surgical Pathologist who is always present during my surgery days. It allows me to obtain Frozen Sections on my surgical specimens (for SCCA and BCCA). When Clear surgical margins are obtained, I can proceed immediately with the constructive part of the procedure. Because of my training I am able to offer my patients a wide range of reconstructive options, from Primary Closure to Skin Grafts to more complex local and regional flaps.


Treatments: Besides surgical excisions, we can offer treatments for advanced skin cancers, like Melanoma, Squamous and Basal Cell Carcinoma. I work closely with our Oncology Dept., which offers the latest treatments available like immunotherapy and targeted therapy for advanced Melanoma. The Oncology Dept. also offers genetic testing and counselling.


Ancillary Services: Considering that most of my surgical patients are older and more frail, the additional resources of the Cardiology Dept., Vascular Surgery Dept, General Surgery Dept. and the Diabetic Clinic help me to optimize the overall medical condition of my surgical patients so as to obtain the best surgical outcomes.


In summary, even though Adirondack Health is a rural community-based hospital, it has the capacity to treat patients with complex skin cancer lesions and to offer them the latest available treatments with streamlined coordination between several Departments. 


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/henri-p-gaboriau-md-nwid-2751.html